Subscribe to RSS
DOI: 10.1160/TH09-09-0645
A meta-analysis of potential risks of low levels of protein Z for diseases related to vascular thrombosis
Publication History
Received:
15 September 2009
Accepted after major revision:
22 January 2009
Publication Date:
22 November 2017 (online)
Summary
The relationship between protein Z levels and thrombosis is controversial. We performed a systematic review and meta-analysis of the available studies to assess the association between protein Z and vascular thrombotic diseases. We conducted an electronic literature search through MedLine, Embase, Google Scholar, Web of Science, The Cochrane Library, bibliographies of retrieved articles and abstracts of congresses up to October, 2009. Studies were included if they analysed protein Z levels in patients with vascular thrombotic diseases. After the review process, 28 case-control studies (33 patient cohorts), including 4,218 patients with thrombotic diseases and 4,778 controls, were selected for analysis. The overall analysis using a random-effects model showed that low protein Z levels were associated with an increased risk of thrombosis (odds ratio [OR] 2.90, 95% confidence interval [CI] 2.05–4.12; p<0.00001). On subgroup analysis, a significant association was found between low protein Z levels and arterial vascular diseases (OR 2.67, 95%CI 1.60–4.48; p=0.0002), pregnancy complications (OR 4.17, 95%CI 2.31–7.52; p<0.00001), and venous thromboembolic diseases (OR 2.18, 95%CI 1.19–4.00; p=0.01). The results of this meta-analysis are consistent with a role for protein Z deficiency in thrombotic diseases, including arterial thrombosis, pregnancy complications and venous thromboembolism.
-
References
- 1 Broze Jr GJ, Miletich JP. Human protein Z. J Clin Invest 1984; 73: 933-938.
- 2 Ichinose A, Takeya H, Espling E. et al. Amino acid sequence of human protein Z, a vitamin K-dependent plasma glycoprotein. Biochem Biophys Res Comm 1990; 172: 1139-1144.
- 3 Han X, Fiehler R, Broze Jr. GJ. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-9255.
- 4 Vasse M. Protein Z a protein seeking a pathology. Thromb Haemost 2008; 100: 548-556.
- 5 Vasse M, Guegan-Massardier E, Borg JY. et al. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933-934.
- 6 Kobelt K, Demarmels Biasiutti F, Mattle HP. et al. Protein Z in ischemic stroke. Br J Haematol 2001; 114: 169-173.
- 7 Gris JC, Quere I, Dechaud E. et al. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-2608.
- 8 Kemkes-Matthes B, Nees M, Kunhel G. et al. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 2002; 106: 183-185.
- 9 Lopaciuk S, Bykowska K, Kwiecinski H. et al. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 536.
- 10 Heeb MJ, Paganini-Hill A, Griffin JH. et al. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-144.
- 11 Koutroubakis I, Theodoropoulou A, Sfiridaki A. et al. Low plasma protein Z levels in patients with ischemic colitis. Dig Dis Sci 2003; 48: 1673-1676.
- 12 Fedi S, Sofi F, Brogi D. et al. Low protein Z plasma levels are independently associated with acute coronary syndromes. Thromb Haemost 2003; 90: 1173-1178.
- 13 McQuillan A, Eikelboom J, Hankey G. et al. Protein Z in ischemic stroke and its etiologic subtypes. Stroke 2003; 34: 2415-2419.
- 14 Ayoub N, Esposito G, Barete S. et al. Protein Z deficiency in antiphospholipid-negative Sneddon’s syndrome. Stroke 2004; 35: 1329-1332.
- 15 Grandone E, Colaizzo D, Cappucci F. et al. Protein Z levels and unexplained fetal losses. Fertil Steril 2004; 82: 982-983.
- 16 Morange PE, Juhan-Vague I. on behalf of the PRIME study group. Protein Z plasma levels are not associated with the risk of coronary heart disease: the PRIME study. J Thromb Haemost 2004; 02: 2050-2051.
- 17 Paidas MJ, Ku DHW, Lee MJ. et al. Protein Z protein S levels are lower in patients with thrombophilia and subsequent pregnancy complications. J Thromb Haemost 2005; 03: 497-501.
- 18 Al-Shanqeeti A, van Hylckama Vlieg A, Berntorp E. et al. Protein Z and protein Z-dependent protease inhibitor. Thromb Haemost 2005; 93: 411-413.
- 19 Sofi F, Cesari F, Vigiani S. et al. Protein Z levels in different phases of activity of coronary atherosclerosis. J Thromb Haemost 2005; 03: 2254-2258.
- 20 Koren-Michowitz M, Eting E, Rahimi-Levene N. et al. Protein Z levels and central retinal vein or artery occlusion. Eur J Haematol 2005; 75: 401-405.
- 21 Bretelle F, Arnoux D, Shojai R. et al. Protein Z in patients with pregnancy complications. Am J Obstet Gynecol 2005; 193: 1698-1702.
- 22 Martinelli I, Razzari C, Biguzzi E. et al. Low levels of protein Z and the risk of venous thromboembolism. J Thromb Haemost 2005; 03: 2817-2819.
- 23 Santacroce R, Sarno M, Cappucci F. et al. Low protein Z levels and risk of occur-rence of deep vein thrombosis. J Thromb Haemost 2006; 04: 2417-2422.
- 24 Kolaitis NJ, Felekis T, Dova L. et al. A high normal value of plasma protein Z is an uncommon finding in non-arteritic ischemic optic neuropathy (N-AION) patients. J Thromb Haemost 2007; 05 (Suppl. 02) P-S-101.
- 25 Erez O, Hoppensteadt D, Romero R. et al. Preeclampsia is associated with low concentrations of protein Z. J Matern Fetal Neonatal Med 2007; 20: 661-667.
- 26 Sofi F, Cesari F, Pratesi G. et al. Low protein Z levels in patients with peripheral arterial disease. Thromb Haemost 2007; 89: 1114-1117.
- 27 Pardos-Gea J, Ordi-Ros J, Serrano S. et al. Protein Z levels and anti-protein Z antibodies in patients with arterial and venous thrombosis. Thromb Res 2008; 121: 727-734.
- 28 van Goor MPJ, Dippel DWJ, Jie KSG. et al. Low protein Z levels but not the protein Z gene G79A polymorphism are a risk factor for ischemic stroke. Thromb Res 2008; 123: 213-218.
- 29 Topalidou M, Effraimidou S, Farmakiotis D. et al. Low protein Z levels, but nor the intron F G79A polymorphism, are associated with unexplained pregnancy loss. Thromb Res 2009; 124: 24-27.
- 30 Grandone E, Favuzzi G, De Stefano V. et al. Protein Z g-42a variant and the risk of pregnancy-related venous thromboembolism in a cohort of Italian patients. Thromb Res 2009; 123: 848-850.
- 31 Sofi F, Cesari F, Tu Y. et al. Protein Z-dependent protease inhibitor and protein Z in peripheral arterial disease patients. J Thromb Haemost 2009; 07: 731-735.
- 32 Le Cam-Duchez V, Soria C, Sollier CBD. et al. Rare genotypes of protein Z gene are a risk factor for premature myocardial infarction but not protein Z plasma level. Thromb Haemost 2009; 102: 131-136.
- 33 Yin ZF, Huang ZF, Cui J. et al. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci 2000; 97: 6734-6738.
- 34 Zhang J, Tu Y, Lu L. et al. Protein Z-dependent protease inhibitor deficiency produces a more severe murine phenotype than protein Z deficiency. Blood 2008; 111: 4973-4978.
- 35 Greten J, Kreis L, Liliensiek B. et al. Localisation of protein Z in vascular lesions of patients with atherosclerosis. VASA 1998; 27: 144-148.
- 36 Heeb MJ, Fisher M, Paganini-Hill A. Association of low protein Z levels with ischemic stroke in young women. Thromb Haemost 2007; 97: 495-496.